FESTE FORMEN EINES CDK4-INHIBITORS

European patent · EP4214202 · In force

Register entry

Publication number
EP4214202
Application number
EP21783049
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 13, 2021
Published
Jul 26, 2023
Granted
Feb 26, 2025
Protection ends at the latest
Sep 12, 2041
Next annual fee due
Sep 30, 2027
IPC classes
C07D 405/14 (2006.01)
A61P 35/00 (2006.01)
A61K 31/506 (2006.01)
Priority
US 202063078636 P 15.09.2020
US 202163240268 P 02.09.2021
PCT application
PCT/IB2021/058320 13.09.2021
PCT publication
WO2022/058871 24.03.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Jan 7, 2026

    Change

    Published in Swissreg on 07.01.2026

  3. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  4. Feb 26, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.02.2025

  5. Feb 26, 2025

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 26.02.2025

Parties

Holder

Pfizer Inc.

66 Hudson Boulevard East, New York, NY 10001-2192, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

CLARK, Wesley Dewitt

Groton, Connecticut 06340, US

DEAL, Judith Gail

San Diego, California 92121, US

SAMAS, Brian Matthew

Groton, Connecticut 06340, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.